Overview

Open Label, Randomized Study of Low Concentration Ioforminol Injections for Use in Abdominal CECT in Healthy Volunteers

Status:
Completed

Trial end date:
2012-08-01

Target enrollment:

Participant gender:

Summary

To optimize both the Ioforminol concentration and dosage(s) for CECT of the abdomen. To evaluate the safety and tolerability of low concentration Ioforminol Injections. Study recruits healthy volunteers.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

GE Healthcare

Collaborators:

Physician Reference Laboratory
Quintiles, Inc.